Aruna Bio Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Aruna Bio General Information

Description

Developer of a neural exosome platform designed to prepare medicine for the treatment of neural diseases. The company's platform harnesses the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders, enabling drug manufacturers to prepare the drug for stroke, traumatic brain, and spinal cord injuries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 184 Collins Industrial Boulevard
  • Suite A
  • Athens, GA 30601
  • United States
+1 (678)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 184 Collins Industrial Boulevard
  • Suite A
  • Athens, GA 30601
  • United States
+1 (678)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aruna Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Secondary Transaction - Private 01-Mar-2026 Completed Clinical Trials - Phase 1
17. Grant 01-Jun-2022 Completed Clinical Trials - Phase 1
16. Later Stage VC 14-Apr-2021 Completed Clinical Trials - Phase 1
15. Debt - PPP 09-Apr-2020 Completed Clinical Trials - Phase 1
14. Grant 18-Sep-2019 Completed Clinical Trials - Phase 1
13. Later Stage VC 24-Jul-2019 Completed Clinical Trials - Phase 1
12. Later Stage VC 19-Jul-2018 Completed Clinical Trials - Phase 1
11. Grant 01-Sep-2017 Completed Clinical Trials - Phase 1
10. Later Stage VC 28-Apr-2017 $3.73M $3.9M Completed Clinical Trials - Phase 1
9. Grant 01-Jan-2017 $725K $164K Completed Clinical Trials - Phase 1
To view Aruna Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aruna Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a neural exosome platform designed to prepare medicine for the treatment of neural diseases. The company's
Drug Delivery
Athens, GA
27 As of 2026

Paris, France
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aruna Bio Competitors (59)

One of Aruna Bio’s 59 competitors is Coave Therapeutics, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Coave Therapeutics Venture Capital-Backed Paris, France
T3D Therapeutics Venture Capital-Backed Durham, NC
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Fauna Bio Venture Capital-Backed Emeryville, CA
Aquinnah Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 59 competitors. Get the full list »

Aruna Bio Patents

Aruna Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260130947-A1 Extracellular vesicles for treatment of amyotrophic lateral sclerosis Pending 07-Jul-2023
WO-2025012776-A1 Extracellular vesicles for treatment of amyotrophic lateral sclerosis Inactive 07-Jul-2023
AU-2021264512-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020
CA-3176495-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020
EP-4142737-A1 Binding agents and uses thereof for central nervous system delivery Pending 27-Apr-2020 A61K47/6901
To view Aruna Bio’s complete patent history, request access »

Aruna Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aruna Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Irrus Investments Angel Group Minority
National Institutes of Neurological Disorders and Stroke Government
Eshelman Ventures Venture Capital Minority
Evolution VC Partners Venture Capital Minority
GRA Venture Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Aruna Bio FAQs

  • When was Aruna Bio founded?

    Aruna Bio was founded in 2003.

  • Where is Aruna Bio headquartered?

    Aruna Bio is headquartered in Athens, GA.

  • What is the size of Aruna Bio?

    Aruna Bio has 27 total employees.

  • What industry is Aruna Bio in?

    Aruna Bio’s primary industry is Drug Delivery.

  • Is Aruna Bio a private or public company?

    Aruna Bio is a Private company.

  • What is Aruna Bio’s current revenue?

    The current revenue for Aruna Bio is .

  • How much funding has Aruna Bio raised over time?

    Aruna Bio has raised $33.4M.

  • Who are Aruna Bio’s investors?

    Irrus Investments, National Institutes of Neurological Disorders and Stroke, Eshelman Ventures, Evolution VC Partners, and GRA Venture Fund are 5 of 7 investors who have invested in Aruna Bio.

  • Who are Aruna Bio’s competitors?

    Coave Therapeutics, T3D Therapeutics, Cristal Therapeutics, Fauna Bio, and Aquinnah are some of the 59 competitors of Aruna Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process